Evaluation of thirty patients with eustachian tube dysfunction in Taiwan by questionnaire survey

Lin, Wei-Lin; Chou, Yi-Fan; Sun, Chuan‐Hung; Lin, Chung-Ching; Hsu, Chuan‐Jen; Wu, Hung‐Pin

doi:10.1016/j.jfma.2019.08.017

Cited by 22 publications

(22 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies that administered the ETDQ‐7 to individuals with or without OETD, as determined by the presence or absence of symptoms and tympanometry prior to administration of the survey, showed ETDQ‐7 scores of ≥14.5 (mean score ≥ 2.1) to be highly sensitive and specific for OETD. Eight studies designed in this manner were identified, including the first description of the ETDQ‐7 by McCoul et al, 4 as well as studies aiming to validate the ETDQ‐7 in Brazilian Portuguese, 9 Chinese, 11 Danish, 12 Dutch, 10 European Portuguese, 6 Hebrew, 8 and Turkish. 5 Within these studies, all control patients were asymptomatic with normal tympanometry and all OETD patients were symptomatic with abnormal tympanometry.…”

Section: Resultsmentioning

confidence: 99%

“…The ETDQ‐7 had both a sensitivity and specificity of 100% when using a total score cut‐off of ≥14.5 among this cohort. Eight studies that were designed in a nearly identical manner, in order to validate the ETDQ‐7 in different languages, have similarly shown a sensitivity and specificity of 91%‐100% and 67%‐100%, respectively 5,8‐12,28 . However, studies that have administered the ETDQ‐7 to cohorts of symptomatic patients who have not previously undergone tympanometry or other objective testing have found much lower rates of sensitivity (49%‐80%) and specificity of (24%‐78%) 16‐18 .…”

Section: Discussionmentioning

confidence: 99%

“…The Eustachian Tube Dysfunction Questionnaire (ETDQ‐7) is a seven‐question survey that was developed in 2012 as a patient‐reported outcome measure to assess the severity of Eustachian tube dysfunction (ETD) symptoms and measure treatment response. 4 Since its development, the ETDQ‐7 has been translated into at least nine languages 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 and used extensively in the assessment of clinical response to balloon dilation of the Eustachian tube (BDET). 13 ETDQ‐7 scores improve with BDET 13 and may also improve following sinus surgery.…”

Section: Introductionmentioning

confidence: 99%

“…Among this cohort of patients, a total ETDQ‐7 score of ≥14.5 had 100% sensitivity and 100% specificity for predicting OETD. Similarly designed studies used to validate translated 5 , 6 , 8 , 9 , 10 , 11 , 12 versions of ETDQ‐7 have found the ETDQ‐7 to have a sensitivity and specificity of >90%, often approaching 100%. However, a recent study by Teixeira et al 16 found that a total score of ≥14.5 on the ETDQ‐7 had a sensitivity and specificity of 54% and 78%, respectively, for predicting OETD identified by pressure chamber and inflation‐deflation testing.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Predictive value of the Eustachian Tube Dysfunction Questionnaire‐7 for identifying obstructive Eustachian tube dysfunction: A systematic review

Andresen

Sharon

Nieman

et al. 2021

Laryngoscope Investig Oto

View full text Add to dashboard Cite

Objective To perform a systematic review to determine if a total score of ≥14.5 (mean score ≥ 2.1) on the ETDQ‐7 accurately identifies patients with obstructive Eustachian tube dysfunction (OETD) on impedance tympanometry (peak compliance <0.2 mL or middle ear pressure of −100 daPa) or other objective measures of OETD. Methods A systematic review without a meta‐analysis was performed of studies in four electronic databases (Pubmed, Embase, Web of Science, and Scopus) that used the ETDQ‐7 and at least one objective measure of OETD. Results Six‐hundred and fifty‐two studies were identified in the initial literature search. Abstracts from 337 studies were screened, followed by full‐text review of 61 studies, and qualitative synthesis of 12 studies. Tympanometry was used as an objective measure in ten studies. Eight of the 12 included studies had patient cohort selection bias. Eight studies administered the ETDQ‐7 in cohorts of patients with or without OETD, already confirmed on tympanometry, and found a sensitivity of 91%‐100% and specificity of 67%‐100%. Four studies administered the ETDQ‐7 to patients who had not previously undergone objective testing and found a sensitivity of 49%‐80% and specificity of 24%‐78%. Conclusions The ETDQ‐7 is an important patient‐reported outcome measure. However, based upon existing literature, the ETDQ‐7 appears limited as a diagnostic tool for OETD or as an objective measure of Eustachian tube function.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Predictive value of the Eustachian Tube Dysfunction Questionnaire‐7 for identifying obstructive Eustachian tube dysfunction: A systematic review

Andresen

Sharon

Nieman

et al. 2021

Laryngoscope Investig Oto

View full text Add to dashboard Cite

show abstract

“…The Valsalva maneuver result was objectively recorded as positive if the investigator could see TM movement or hear the sound of air flow within the TM. The ETDQ-7 is a validated, standardized, seven-item patient-reported questionnaire for assessing symptom severity associated with ETD [ 18 ]. The questionnaire is not specific for laterality of the affected ear(s).…”

Section: Methodsmentioning

confidence: 99%

Microwave ablation eustachian tuboplasty: A preliminary investigation with long-term follow-up

Lou¹,

Lou

Sun³

et al. 2021

Journal of Otolaryngology - Head & Neck Surgery

View full text Add to dashboard Cite

Objectives This study was performed to evaluate the efficacy of microwave ablation (MWA) eustachian tuboplasty for the treatment of patients with retracted tympanic membrane (TM) due to eustachian tube dysfunction (ETD). Methods This was a prospective study of 20 patients with ETD (middle ear atelectasis) who underwent MWA eustachian tuboplasty. Outcomes included the ability to perform a Valsalva maneuver, audiometry results, tympanometry results, ETD Questionnaire (ETDQ-7) score, and TM status. Results Eighteen patients (18 ears) were included in this study. There were statistically and clinically significant improvements in the mean ETDQ-7 score at 6 months postoperatively (change in mean score of 16.7 ± 3.6, P < 0.001) and at 30 months postoperatively (change in mean score of 18.9 ± 2.9, P < 0.001). Type A tympanogram was obtained in 27.8% of patients (5/18) at 6 months postoperatively, and in 77.7% at 30 months postoperatively. A Valsalva maneuver was possible in 72.2% of patients at 6 months postoperatively and in 88.9% of patients at 30 months postoperatively. In addition, the ears of 13 patients (72.2%) showed both normal tympanograms and TM at 30 months postoperatively. Interestingly, 38.5% of patients (5/13) exhibited complete sclerosis of the pars tensa. None of the patients experienced severe MWA-related complications during follow-up. Conclusions MWA eustachian tuboplasty is a feasible alternative to conventional tuboplasty, and can improve subjective and objective outcomes in patients with ETD for up to 30 months following treatment. In addition, this study showed that the extent of sclerotic plaque increased over time, whereas the extents of atrophy and tensa retraction decreased following tuboplasty in most patients. Graphical abstract

show abstract

Combined balloon Eustachian tuboplasty/endoscopic sinus surgery for patients with chronic rhinosinusitis and Eustachian tube dysfunction

Hsieh,

Lin,

Lin

et al. 2024

Int Forum Allergy Rhinol

View full text Add to dashboard Cite

BackgroundTo elucidate the role of balloon Eustachian tuboplasty (BET) in the management of chronic rhinosinusitis with obstructive Eustachian tube dysfunction (ETD), we evaluated the results of endoscopic sinus surgery (ESS) with and without BET in patients with chronic rhinosinusitis with obstructive ETD.MethodsThis randomized controlled trial conducted in a single‐institution tertiary care center setting included 50 patients diagnosed with primary chronic rhinosinusitis and obstructive ETD between July 2018 and June 2022. Twenty‐five patients were prospectively enrolled for combined ESS/BET. The control group (25 patients) underwent ESS alone. Outcome measurements of the Sinonasal Outcome Test 22, modified Lund–Kennedy score, Eustachian Tube Dysfunction Questionnaire‐7 (ETDQ‐7), and serial Eustachian tube function test results were analyzed 3 months postoperatively.ResultsThe improvement (12.60 ± 6.50) in the ETDQ‐7 score in the BET group was significantly higher than that in the control group (6.60 ± 5.58). The ratio of improvement in the ETDQ‐7 score was also significantly higher in the BET than in the control group (92% vs. 68%, p = 0.034). Logistic regression analysis showed that performing BET (odds ratio [OR]: 5.41, 95% confidence interval [CI]: 1.02–28.79, p = 0.048) and a low post‐modified Lund–Kennedy score (OR: 0.15, 95% CI: 0.04–0.54, p = 0.004) were significantly associated with ETDQ‐7 score improvement.ConclusionCombined BET/ESS could decrease otologic symptoms and improve Eustachian tube function. BET may be an appropriate adjunctive procedure for treating chronic rhinosinusitis with obstructive ETD.

show abstract

Evaluation of thirty patients with eustachian tube dysfunction in Taiwan by questionnaire survey

Cited by 22 publications

References 10 publications

Predictive value of the Eustachian Tube Dysfunction Questionnaire‐7 for identifying obstructive Eustachian tube dysfunction: A systematic review

Predictive value of the Eustachian Tube Dysfunction Questionnaire‐7 for identifying obstructive Eustachian tube dysfunction: A systematic review

Microwave ablation eustachian tuboplasty: A preliminary investigation with long-term follow-up

Combined balloon Eustachian tuboplasty/endoscopic sinus surgery for patients with chronic rhinosinusitis and Eustachian tube dysfunction

Contact Info

Product

Resources

About